Filter
1125
Text search:
medicines
quality
assurance
Featured
Recommendations
135
New Publications
408
Language
Document type
No document type
671
Guidelines
157
Studies & Reports
130
Manuals
65
Strategic & Response Plan
65
Training Material
15
Situation Updates
9
Fact sheets
8
Infographics
4
Resource Platforms
1
Countries / Regions
India
60
Kenya
54
Uganda
48
Ethiopia
42
Nigeria
33
Global
33
South Africa
31
Zambia
29
Malawi
29
Nepal
28
Tanzania
27
Liberia
26
Ghana
25
Sierra Leone
24
Namibia
24
Bangladesh
23
Rwanda
20
Western and Central Europe
18
Myanmar / Burma
15
Asia
12
Africa
12
Zimbabwe
10
Latin America and the Carribbean
10
Eastern Europe
10
Botswana
9
Ukraine
8
Lesotho
8
Haiti
7
Philippines
7
South–East Asia Region
7
Pakistan
6
Cambodia
6
Congo, Democratic Republic of
5
Indonesia
5
Eswatini/ Swaziland
5
West and Central Africa
5
Middle East and North Africa
5
Burkina Faso
4
Senegal
4
East and Southern Africa
4
Georgia
4
Guinea
3
Cameroon
3
Iraq
3
Jordan
3
Syria
3
Mozambique
3
Sudan
3
Western Pacific Region
3
Albania
3
Saudi Arabia
2
Somalia
2
Lebanon
2
Thailand
2
Benin
2
Bhutan
2
Southern Africa
2
Laos
2
Tajikistan
2
Russia
2
Mali
1
Morocco
1
Afghanistan
1
Chad
1
Gambia
1
Papua New Guinea
1
North Macedonia
1
Greece
1
Libya
1
Madagascar
1
Sri Lanka
1
Yemen
1
Eastern Europe and Central Asia
1
Paraguay
1
Fiji
1
Venezuela
1
Timor Leste/ East Timor
1
Iran
1
Australia
1
Vietnam
1
North America
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
584
Clinical Guidelines
103
Public Health
57
Women & Child Health
43
Pharmacy & Technologies
32
Key Resources
29
Capacity Building
14
Annual Report MEDBOX
2
General Guidelines
1
Protection & Security
1
Toolboxes
TB
95
AMR
87
Pharmacy
86
HIV
75
COVID-19
33
Caregiver
29
Mental Health
23
NTDs
20
Rapid Response
16
Ebola
13
Global Health Education
12
Planetary Health
12
Disability
10
Conflict
10
NCDs
10
Refugee
5
Health Financing Toolbox
5
Cholera
4
Natural Hazards
4
Polio
2
Zika
1
Specific Hazards
1
Health Financing
1
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Le présent document qui fait suite à la recommandation ci-dessus citées se veut une
traduction de l’objectif n°4 du Plan National de Développement Sanitaire (PNDS)3
. Il
traduit la volonté du gouvernement burkinabé de développer un cadre de référence
pour tout intervenant dans le dom
...
Annex 5, WHO Technical Report Series 1010, 2018
Guidance for the preparation and submission of dossiers
The second ECDC/EFSA/EMA joint report on the integrated analysis of antimicrobial consumption (AMC) and antimicrobial resistance (AMR) in bacteria from humans and food-producing animals addressed data obtained by the Agencies’ EU-wide surveillance networks for 2013–2015. AMC in both sectors, exp
...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Malawi Health Sector Strategic Plan 2011 - 2016
recommended
Moving towards equity and quality